Interní Med. 2003; 5(7): 333-337

Ambulantní antitrombotická léčba

prof. MUDr. Václav Čepelák DrSc
Městská nemocnice v Plzni

Keywords: low-molecular-weight heparin, deep venous thrombosis, outpatient treatment, oral anticoagulants.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čepelák V. Ambulantní antitrombotická léčba. Interní Med. 2003;5(7):333-337.

Nízkomolekulární hepariny se ukázaly jako účinné a bezpečné léky hluboké žilní trombózy u ambulantních pacientů. Článek se zabývá podmínkami provádění ambulantní léčby podle doporučení České angiologické společnosti. Prodloužená ambulantní profylaxe nízkomolekulárními hepariny po propuštění z nemocnice je schopna významně snížit četnost tromboembolických komplikací u chirurgických pacientů s vysokým rizikem trombózy. Při kontrole ambulantní léčby kumarinovými antikoagulancii lze využít miniaturních analyzátorů schopných stanovit protrombinový čas a INR z kapky plné krve odebrané z prstu.

ANTITHROMBOTIC TREATMENT IN OUTPATIENTS

Low-molecular-weight heparins have been shown to be effective and safe in the treatment of deep venous thrombosis in outpatients. The article reviews criteria for outpatient management according to recommendations of Czech Society of Angiology. Prolonged outpatient prophylaxis with low-molecular-weight heparins after hospital discharge is able to significantly reduce the incidence of thromboembolic complications in high-risk surgical patients. Outpatient treatment with oral anticoagulants can be optimized by the use of mini-analyzers able to determine prothrombin time from a drop of fingerstick whole blood.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bergquist D, et al. for the ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346: 975-980. Go to original source... Go to PubMed...
    2. Boccalon H, et al. for the Vascular Midi-Pyrenées Network Group. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin. Arch Intern Med. 2000; 160: 1769-1773. Go to original source... Go to PubMed...
    3. Čepeláková H. Doporučení pro léčení žilní trombózy v ambulantní praxi. Doporučený postup České angiologické společnosti. Cor Vasa 2003; 45: K 43-K 44.
    4. DVT treatment: In hospital or at home? Towards an harmonised practice. Results of an international survey. DVT Forum 1998; 1: 1-8.
    5. Hull RD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001; 135: 858-869. Go to original source... Go to PubMed...
    6. Chai SJ, Macik G. Improving the safety profil of warfarin. Semin Hematol 2002; 39: 179-186. Go to original source... Go to PubMed...
    7. Koopman MMW, et al. for the TASMAN Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med.1996; 334: 682-687. Go to original source... Go to PubMed...
    8. Kvasnička J. Trombofilie a trombotické stavy v klinické praxi. Praha: Grada Avicenum 2003: 300 s.
    9. Levine M, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal dep-vein thrombosis. N Engl J Med. 1996; 334: 677-681. Go to original source... Go to PubMed...
    10. Malý J. Ambulantní antikoagulační léčba kumariny. Interní medicína pro praxi 2002; 4: 460-466.
    11. Offermann M, et al. Die ambulante Therapie der akuten tiefen Beinvenenthrombose. Erfahrungen aus zwei Praxen fur Gefäßkrankheiten in Deutschland. Dtsch Med Wochenschr. 2001; 126: 1164-1167. Go to original source... Go to PubMed...
    12. Partsch H. Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. VASA 2001; 30: 195-204. Go to original source... Go to PubMed...
    13. Samama ChM, et al. for the SACRE Study Investigators. Extended venous thromboembolism prophylaxis after total hip replacement. A comparison of low-molecular-weight heparin with oral anticoagulants. Arch Intern Med 2002; 162: 2191-2196. Go to original source... Go to PubMed...
    14. Spyropoulos AC, et al. Management of acute proximal deep vein thrombosis. Pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin. CHEST 2002; 122: 108-114. Go to original source... Go to PubMed...
    15. Van den Belt A.G.M. et al. for the TASMAN Study Group. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis. an economic evaluation. Thromb. Haemost. 1998; 79: 259-263. Go to original source... Go to PubMed...
    16. Wells PS, et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. A comparison of patient self-injection with homecare injection. Arch Intern Med 1998; 158: 1809-1812. Go to original source... Go to PubMed...
    17. White RH, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158: 1525-1531. Go to original source... Go to PubMed...
    18. Widimský J, Malý J. Akutní plicní embolie a žilní trombóza. Praha: Triton 2002: 304 s.
    19. Yacovella T, Alter M. Antikoagulační léčba žilní tromboembolické nemoci. Jaké jsou současné možnosti? Medicína po promoci 2001; 2: 47-55.
    20. Zeman J, et al. Zjišťování rizika trombózy dolních končetin po implantaci endoprotézy kyčelního kloubu ve fázi rehabilitace po propuštění z nemocnice. Praktická flebologie 1999; 8: 20-26.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.